GT
TAK icon

Greenleaf Trust’s Takeda Pharmaceutical TAK Stock Holding History

Greenleaf Trust’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,141
Closed -$219K – 790
2023
Q3 		$219K Buy
14,141
+2,168
+18% +$33.6K ﹤0.01% 685
2023
Q2 		$188K Buy
11,973
+339
+3% +$5.55K ﹤0.01% 731
2023
Q1 		$192K Buy
+11,634
New +$185K ﹤0.01% 740
2022
Q4 		– Sell
-22,884
Closed -$297K – 769
2022
Q3 		$297K Sell
22,884
-6,034
-21% -$83.9K ﹤0.01% 538
2022
Q2 		$406K Sell
28,918
-16,168
-36% -$231K 0.01% 465
2022
Q1 		$646K Buy
45,086
+14,484
+47% +$213K 0.01% 345
2021
Q4 		$417K Buy
30,602
+7,674
+33% +$108K ﹤0.01% 483
2021
Q3 		$376K Buy
22,928
+5,796
+34% +$97.3K ﹤0.01% 500
2021
Q2 		$288K Sell
17,132
-7,564
-31% -$129K ﹤0.01% 590
2021
Q1 		$451K Buy
+24,696
New +$444K 0.01% 409
2020
Q4 		– Sell
-19,502
Closed -$348K – 637
2020
Q3 		$348K Buy
19,502
+5,324
+38% +$96.9K 0.01% 374
2020
Q2 		$254K Buy
+14,178
New +$255K ﹤0.01% 441
2020
Q1 		– Sell
-19,386
Closed -$382K – 589
2019
Q4 		$382K Sell
19,386
-3,302
-15% -$63.2K 0.01% 353
2019
Q3 		$390K Buy
+22,688
New +$392K 0.01% 340
2019
Q2 		– Sell
-16,254
Closed -$331K – 562
2019
Q1 		$331K Buy
+16,254
New +$327K 0.01% 364

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Greenleaf Trust's TAK Position: Q4 2023 in Review

Greenleaf Trust sold out of Takeda Pharmaceutical (TAK) in Q4 2023, closing a stake of 14,141 shares — an estimated $219K sold.

Greenleaf Trust first reported a position in TAK in Q1 2019 and held it in 15 quarters. The position peaked at $646K in Q1 2022. 307 funds tracked by Wall St. Rank hold TAK as of Q4 2023.

  • Greenleaf Trust reported no remaining Takeda Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Greenleaf Trust sold 14,141 Takeda Pharmaceutical shares in Q4 2023, an estimated $219K.
  • Greenleaf Trust first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 15 quarters.
  • Greenleaf Trust's Takeda Pharmaceutical position peaked at $646K in Q1 2022.
  • 307 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2023.

Based on Greenleaf Trust's 13F filing for Q4 2023, filed 31 Jan 2024.